CXCL10 and hepatocellular carcinoma: Consistent with the results of MDSC analysis, the intragraft expressions of CXCL10 (p = 0.0068) and TLR4 (p = 0.0056) were also significantly up-regulated in the patients with HCC recurrence in contrast with those without HCC recurrence (Fig. 2B).